RNA Insights

Dive into our team's latest insights about life sciences deal making, transaction support and value creation.

Thomas Foster Joins RNA Advisors as Managing Principal

RNA Advisors, LLC, a leading valuation and strategic... [read more]

Fairness Opinions: Why Expertise Matters Now More Than Ever in Life Sciences and Healthcare

Since 2015, RNA Advisors has provided valuation, transactional... [read more]

Scott Winder joins RNA to expand its Life Science Tax and Financial Reporting Valuation Group

RNA Advisors, LLC, a leading valuation and strategic... [read more]

Client Success: Healthcare Transaction Support to Assess Value from Different Perspectives

By Jeff Williamson THE SITUATION: A healthcare company... [read more]

Client Success: Mandatory Adoption of ASC 842 – Incremental Borrowing Rate Analysis for Private Biotech

By Jeff Suchocki, CFA The Situation: Adoption of... [read more]

Client Success: Strategic Extension for Revenue-Stage Medtech Company

By Jeff Williamson THE SITUATION: A medical device... [read more]

Client Success: Navigating Strategic Investment in Healthcare Technology

THE PROBLEM: A healthcare technology company that sells... [read more]

RNA Proudly Welcomes Jeff Williamson

Jeff Williamson has joined the RNA Advisors growing... [read more]

Client Success: Incremental Borrowing Rate Analysis for Publicly Traded, Clinical Stage Biotech

THE PROBLEM: A publicly traded clinical stage biotech... [read more]

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.